Search results
BMO raises Scholar Rock shares target on SAPPHIRE trial optimism By Investing.com
Investing.com· 2 days agoOn Thursday, BMO Capital Markets adjusted its outlook on Scholar Rock (NASDAQ:SRRK) shares,...
Lixte Biotechnology inks deal for cancer drug trial By Investing.com
Investing.com· 18 hours agoLixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) has entered into a significant agreement with the...
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 19 hours agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Akero Therapeutics executive sells over $53k in company stock By Investing.com
Investing.com· 1 day agoThe total value of the shares sold amounted to approximately $53,885, reflecting a weighted-average...
Akero Therapeutics CEO sells shares worth over $178k By Investing.com
Investing.com· 1 day agoThe shares sold by Cheng were part of a "sell-to-cover" policy employed by Akero Therapeutics to...
JPMorgan's Top Strategist Sticks To Bearish S&P 500 Forecast, Warns Of 2008-Like Crash: 'Equities...
Benzinga via AOL· 4 days agoJPMorgan Chase & Co. continues to hold one of the most pessimistic views on Wall Street regarding...
Better Cybersecurity Stock: Palo Alto Networks vs. Fortinet
Motley Fool via Yahoo Finance· 4 days agoFortinet's growth is more balanced across its secure ops, secure access service edge (SASE), and...
ProKidney director Pablo Legorreta buys $54.7 million in shares By Investing.com
Investing.com· 13 hours agoIn a notable transaction, Pablo Legorreta, a director and significant shareholder of ProKidney Corp....
Oppenheimer cuts Spruce Biosciences shares target, cites updated revenue forecasts By Investing.com
Investing.com· 2 days agoOn Thursday, Oppenheimer adjusted its price target for Spruce Biosciences, Inc. (NASDAQ:SPRB)...
The 8 Most Supportive (and Comfortable) Sports Bras for Bigger Cup Sizes
Runner's World via Yahoo News· 4 days agoFit your sports bra by moving your breasts so they are sitting squarely in the cups and aren’t...